SHIBUYA CORPORATION
6340・Prime Market・Machinery
Packaging Plant Business
Shibuya Kogyo's core business, providing filling and packaging systems for beverages, food, and pharmaceuticals.
| Period | Current | Previous | Change |
|---|---|---|---|
| Sales (Cumulative Nine Months of FY2026, ending June 2026) | ¥63,443 million | ¥57,709 million (same period of prior year) | ↑ |
| Segment Profit (Cumulative Nine Months of FY2026, ending June 2026) | ¥10,056 million | ¥9,588 million (same period of prior year) | ↑ |
| Segment Profit Margin (Cumulative Nine Months of FY2026, ending June 2026) | 15.8% | 16.6% (same period of prior year) | ↓ |
| Sales (Full Year FY2025, ended June 2025) | ¥80,081 million | — | — |
| Segment Profit (Full Year FY2025, ended June 2025) | ¥12,574 million | — | — |
| Orders Received (Cumulative Nine Months of FY2026, ending June 2026) | ¥56,382 million | ¥54,365 million (same period of prior year) | ↑ |
| Order Backlog (as of end of March 2026) | ¥65,812 million | ¥76,313 million (end of same period prior year) | ↓ |
Business Details
Manufactures and sells Bottling Systems (Filling / Capping / Labeling), Pharmaceutical Equipment Systems (Pharmaceutical Manufacturing System / Isolator), Regenerative Medicine Systems (Cell Culture Isolator / Robotic Automated Cell Culture System), and other equipment for soft drink, alcoholic beverage, food, pharmaceutical, and cosmetics manufacturers. The domestic market share for Beverage Aseptic Filling Systems is estimated at 80-90%, reflecting high technological superiority. This is the company's core segment, accounting for approximately 62% of consolidated sales (FY2025, ending June 2025). Major customers include domestic and overseas food, beverage, and pharmaceutical manufacturers.
Recent Overview
The pharmaceutical and cosmetics plant category posted a substantial increase in sales; overall segment sales rose 9.9% and profit rose 4.9% year on year.
In the cumulative nine months of FY2026 (July 2025-March 2026), Packaging Plant Business sales were ¥63,443 million (up 9.9% year on year), with segment profit of ¥10,056 million (up 4.9% year on year). The pharmaceutical and cosmetics plant category led growth, rising 34.0% year on year to ¥13,875 million, driven by increases in injectable drug vial filling systems and automated cell culture systems for Thailand. The alcoholic beverage plant category also grew 36.1% year on year on increased sake filling systems. The food plant category posted a slight increase (up 2.5% year on year) due to growth in sales to China and Southeast Asia. On the other hand, the order backlog declined to ¥65,812 million, down 13.8% from the end of the same period of the prior year, warranting close attention as a leading indicator of future sales.
Key Products
Growth Drivers
- Expanding demand for Beverage Aseptic Filling Systems both domestically and overseas (China, Southeast Asia, North America)
- Increased orders for pharmaceutical and cosmetics plants (injectable drug vial filling and cosmetics filling lines)
- Development of emerging markets for Regenerative Medicine Systems (automated cell culture systems), such as Thailand and other parts of Asia
- Demand stimulation through environmentally friendly new products, such as electron beam bottle sterilization methods
- Overseas market expansion in emerging Asian countries driven by rising hygiene awareness and income levels
Risks
- Uncertainty over future sales due to a decline in the order backlog (¥65,812 million as of end of March 2026, down 13.8% from the end of the same period of the prior year)
- Risk of cost ratio deterioration due to an increasing proportion of third-party products incorporated into turnkey orders
- Long-term contraction of the domestic beverage market due to the declining birthrate and population decline
- Impact of global economic uncertainty stemming from U.S. tariff policy and other factors on capital expenditure demand
- Profit pressure from rising raw material prices and energy costs
Last updated: September 24, 2025